Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-01

Clinical Trial Update: Intravenous Stem Cells After Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intravenous stem cells after ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intravenous stem cells

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Ischemia, Stroke | Phase 2 | Status: COMPLETED